🚨 Double Shock for Indian Markets: Nifty Crashes 672 Points!

This week, Indian markets were rocked by two major shocks from the U.S.. First, President Donald Trump proposed a massive H1-B visa fee hike up to $100,000, raising concerns for Indian IT giants like

, , and . Then came an even bigger blow — Trump announced a 100% tariff on branded and patented pharmaceutical imports starting October 1, unless companies are building plants in America. This triggered heavy selling in pharma counters such as Laurus Labs, Biocon, and Zydus Life. As a result, the Nifty-50 tanked 672 points (-2.65%) for the week, marking its 5th consecutive negative close and breaking a 3-week winning streak. 👉 Is this just panic or the start of deeper troubles?